CLINICAL_TRIALS
trial_result
· 2025-03-24
Clinical Trial Update: A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002) [Phase 1]
Summary
Phase 1 study of MK-6194 (PT101) in active ulcerative colitis has completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED | Results posted: 2025-03-24